id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_i4syyk3brjbf5djoodjrzptkga	C. Wieser	Pure red cell aplasia after treatment of renal anaemia with epoetin theta	2013	4	.pdf	application/pdf	3040	450	30	Pure red cell aplasia after treatment of renal anaemia Keywords: anti-erythropoietin antibodies; biopharmaceuticals; pure red cell aplasia The introduction of erythropoiesis-stimulating agents (ESAs) appeared to be a milestone, enabling physicians to avoid red antibody-mediated, pure red cell aplasia (PRCA). resistance to therapy with ESAs and detection of neutralizing antibodies against erythropoietin. anti-erythropoietin antibodies using radioimmunoprecipitation (RIP), with negative results (Laborinstitut Prof. Subsequently, the patient changed to a different dialysis centre, where he was switched to epoetin beta. 2012, we repeated the test for anti-erythropoietin antibodies in two different laboratories: (i) Laborinstitut Prof. administration of any ESA and switched the patient to major causes have been identified: (i) changes to the threedimensional (3D) structure of the protein (protein aggregation) and (ii) route of administration. Antibodymediated pure red cell aplasia in chronic kidney disease agents and antibody-mediated pure red-cell aplasia: here are antibody-mediated pure red cell aplasia after treatment	./cache/work_i4syyk3brjbf5djoodjrzptkga.pdf	./txt/work_i4syyk3brjbf5djoodjrzptkga.txt